Brief: Nevro Announces Positive Medicare Coverage Update From Noridian For Treatment Of Painful Diabetic Neuropathy
March 7 (Reuters) - Nevro Corp NVRO.N :
* NEVRO ANNOUNCES POSITIVE MEDICARE COVERAGE UPDATE FROM
NORIDIAN
FOR THE TREATMENT OF PAINFUL DIABETIC NEUROPATHY
* NEVRO CORP - CHANGE WAS POSTED ON MARCH 4, 2022 AND IS
RETROACTIVE FOR PROCEDURES PERFORMED ON OR AFTER JANUARY 1, 2022
Source text for Eikon: ID:nPn6YB5Rfa
Further company coverage: NVRO.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Nevro
See all newsNevro Corp reports results for the quarter ended December 31 - Earnings Summary
Nevro Corp expected to post a loss of 77 cents a share - Earnings Preview
Nevro Corp expected to post a loss of 77 cents a share - Earnings Preview
Nevro Corp expected to post a loss of 78 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Altus Power, Amazon, Nevro